Study identifier:NIS-RCZ-SYM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Utilization of fixed combination (budesonide/formoterol and salmeterol/fluticasone and beclomethasone/formoterol) in treatment of asthma patients in real life condition in Czech Republic (UFO)
asthma
-
No
-
All
2815
Observational
6 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|